Nu Skin Enterprises

Nu Skin Enterprises, Inc. is a holding company, which engages in the development and distribution of personal care products and nutritional supplements. It operates through the following segments: Mainland China, Americas, South Korea, Southeast Asia/Pacific, EMEA, Japan, Hong Kong/Taiwan, Nu Skin Other, Manufacturing, Grow Tech, and Rhyz Other. The first seven segments represent the Nu Skin geographic operations. The last three segments deal with Rhyz investments. Its brands include Nu Skin and Pharmanex. The company was founded by Blake M. Roney, Sandra N. Tillotson, and Steven J. Lund in 1984 and is headquartered in Provo, UT.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Nu Skin Enterprises reports $2.23B revenue for 2022, focuses on innovation and social commerce

Nu Skin Enterprises navigated challenges in 2022, focusing on innovation and social commerce to drive revenue growth. The company aims to overcome challenges in 2023 and achieve Nu Vision 2025 goals through strategic initiatives. Nu Skin's emphasis on enhancing the iO experience and optimizing expenses positions it for sustainable value to investors.

Nu Skin Enterprises meets Q1 expectations, eyes growth in Asia

Nu Skin's Q1 performance in line with expectations, with notable success in key markets like South Korea and Mainland China.
Challenges persist in certain regions due to macroeconomic factors, necessitating strategic adjustments for sustained growth.
Opportunities lie in expanding TRMe program, leveraging digital initiatives, and driving operational improvements for long-term value creation.

Nu Skin reports robust Q2 earnings, eyes growth through acquisitions

Nu Skin Enterprises delivered strong Q2 results driven by Mainland China growth, with revenue of $500.3 million and EPS of $0.54. The company faces challenges in other markets due to macro-related pressures.
Strategic acquisitions of BeautyBio and LifeDNA aim to enhance Nu Skin's core business through personalization and technology. The company's focus on innovation and market trends presents growth opportunities.
With a clear strategic direction, Nu Skin is poised to navigate challenges, capitalize on opportunities, and drive continued growth in the beauty and wellness industry.

Nu Skin reports Q3 revenue of $499M, adjusts 2023 guidance

Nu Skin adjusts 2023 guidance, expecting revenue of $1.92B to $1.96B and EPS of negative $0.10 to $0.05. The company is streamlining expenses and maximizing cash flow.

Nu Skin surpasses Q4 revenue targets, eyes growth opportunities

Nu Skin Enterprises delivered strong Q4 results, exceeding revenue guidance and showcasing a focus on innovation and strategic growth initiatives.
Despite challenges in certain regions, the company demonstrated resilience and stability in key markets, laying the groundwork for future expansion and market penetration.
By rebalancing dividends for growth investments and prioritizing reinvestment in the business, Nu Skin is poised to capitalize on opportunities for market diversification and sustainable growth.
With a clear roadmap for 2024, including product launches, market entries, and capital reallocation strategies, Nu Skin is well-positioned to drive performance and enhance shareholder value.

Nu Skin Enterprises reports robust Q1 earnings, eyes global expansion

Nu Skin Enterprises showcased resilience in revenue and earnings, driven by strong performance in core and new business segments.
While facing challenges from macroeconomic factors, the company is strategically focused on innovation, cost efficiency, and market expansion.
Opportunities lie in product diversification, market entries, and sustainability efforts, positioning Nu Skin for future growth and market leadership.

Nu Skin surpasses Q2 revenue targets, eyes growth amid challenges

Nu Skin Enterprises delivered strong Q2 performance, exceeding revenue guidance and showcasing financial discipline. Despite challenges in China and FX pressures, the company remains focused on innovation and growth. Strategic investments in new products, markets, and brand awareness position Nu Skin for future success. Revised guidance reflects adaptability to market conditions and commitment to long-term vision.

Nu Skin Enterprises meets Q3 guidance, eyes India expansion

Nu Skin's Q3 performance reflects a balanced approach to addressing challenges and leveraging strengths.
Strategic initiatives to drive growth, optimize operations, and expand into new markets are key focus areas.
Despite market pressures, Nu Skin's focus on innovation and efficiency bodes well for future growth.
Overall, Nu Skin's financials and strategic direction indicate a resilient and forward-thinking company.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Nu Skin Enterprises, Inc. is a holding company, which engages in the development and distribution of beauty and wellness solutions. It operates through the following segments: Mainland China, Americas, South Korea, Southeast Asia/Pacific, EMEA, Japan, Hong Kong/Taiwan, Nu Skin Other, Manufacturing, and Rhyz Other. The company was founded by Blake M. Roney, Sandra N. Tillotson, and Steven J. Lund in 1984 and is headquartered in Provo, UT.

Nu Skin (NUS) is battling headwinds in Mainland China thanks to increased scrutiny by the government. Also, management provides an unimpressive view for 2019.

Nu Skin Plunges in 6 Months, Mainland China Woes Persist

Nu Skin's (NUS) third-quarter earnings are affected by limited sales meetings in Mainland China.

Nu Skin's (NUS) Q3 Earnings Beat Estimates, Revenues Miss

Nu Skin Enterprises, Inc. (NUS) CEO Ritch Wood on Q3 2019 Results - Earnings Call Transcript

Nu Skin (NUS) delivered earnings and revenue surprises of 3.95% and -2.57%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Nu Skin Enterprises (NUS) Tops Q3 Earnings Estimates

Shares of Nu Skin Enterprises Inc. NUS, -0.71% fell more than 7% in the extended session Tuesday after the maker of supplements and personal care products reported third-quarter earnings above expectations but sales missed the mark.

Nu Skin misses Q3 sales views, pins it on China weakness

Nu Skin's (NUS) third-quarter 2019 results are expected to reflect impacts of foreign currency headwinds.

Here's How Nu Skin (NUS) Looks Just Ahead of Q3 Earnings

Inter Parfums

NUS vs. IPAR: Which Stock Is the Better Value Option?

NUS vs. IPAR: Which Stock Should Value Investors Buy Now?

Nu Skin (NUS) is battling headwinds in Mainland China that led to an unimpressive view for 2019. However, a rising customer base bodes well.

Nu Skin's Customer Base Bodes Well, Mainland China is a Worry

Nu Skin (NUS) is battling headwinds in Mainland China, stemming from the government's campaign to scrutinize offerings of direct selling and health products industries.

Nu Skin Down 12% in 3 Months, Mainland China is a Concern

Nu Skin (NUS) reported earnings 30 days ago. What's next for the stock?

Nu Skin (NUS) Up 1.3% Since Last Earnings Report: Can It Continue?

Headwinds in Mainland China were a drag on Nu Skin's (NUS) revenues and earnings in the second quarter of 2019.

Nu Skin (NUS) Q2 Earnings In Line With Estimates, Sales Miss

Nu Skin Enterprises, Inc. (NUS) CEO Ritch Wood on Q2 2019 Results - Earnings Call Transcript

Nu Skin (NUS) delivered earnings and revenue surprises of 0.00% and -1.53%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Nu Skin Enterprises (NUS) Meets Q2 Earnings Estimates

Nu Skin's (NUS) Q2 performance is likely to be hurt by the government campaign in Mainland China to inspect offerings of direct selling industries and health products.

Is a Disappointment in Store for Nu Skin (NUS) Q2 Earnings?

NUS or IPAR: Which Is the Better Value Stock Right Now?

The multilevel marketing company just reduced its full-year outlook. Here's why.

Why Nu Skin Enterprises Stock Dropped Today

LM Ericsson Telefon

Textron

These stocks helped contribute to the broader market's losses.

Why Textron, Nu Skin Enterprises, and Ericsson Slumped Today

Nu Skin Enterprises, Inc. (NYSE: NUS) shares are in free fall mode after reporting weak preliminary second-quarter earnings guidance.

DA Davidson Gives Nu Skin Price Target A Chemical Peel

Nu Skin Enterprises Inc. NUS, -16.70% stock plummeted 16.4% in Wednesday trading after the health, wellness and beauty company cut its guidance due to problems in the Chinese market.

Nu Skin shares plummet, stock downgraded after guidance slashed

Nu Skin's (NUS) Q2 and 2019 results are likely to be hurt by weak performance in China, triggered by government's product review initiatives.

Nu Skin Trims View on Anticipated Declines in Mainland China

Shares of beauty and wellness products company Nu Skin tanked on Wednesday after the company said China's crackdown on health products is weighing on sales.

Nu Skin shares plunge 20% as China crackdown hits revenues

Nu Skin Enterprises (NYSE: NUS) shares are trading sharply lower after the company reported worse-than-expected preliminary second-quarter EPS and sales results.

Nu Skin Enterprises Cuts Guidance, Shares Fall 20%

Nu Skin Enterprises Inc. shares fell in the extended session Tuesday after the beauty and wellness products maker cut its outlook.

Nu Skin stock falls after outlook cut on China sales

Nu Skin's (NUS) customer base rises steadily, courtesy of effective marketing strategies and launches. However, adverse impacts of currency rates are concerns.

News for Nu Skin Enterprises Stock (NUS)